Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players - farmdoc daily

farmdocdaily.illinois.edu · 2,236 words · saved by 1 readers

Glucagon-like peptide-1 receptor agonists, often abbreviated as GLP-1, have taken the dieting world by storm, with far-reaching implications for how we eat. Indeed, the explosion of interest in GLP-1 medications, such as Ozempic and Wegovy, has already begun to generate waves far beyond the healthcare sector. While these drugs were initially developed to manage diabetes, their increasing use for weight loss is altering consumer behavior in ways that could significantly impact the entire food supply chain. Early evidence suggests that individuals using GLP-1s spend significantly less money at the grocery store, shifting their purchasing habits away from snacks, alcohol, and carbohydrates while also increasing demand for high-protein and nutrient-dense foods (e.g., Roe, 2025; Hristakeva, et al. , 2024; Bettadapura et al., 2024; Moran, 2025; Balagtas, et al., 2024; Bina and Tonsor, 2025). The use of the drugs has increased substantially in recent years (e.g., Lee, et al., 2024; Montero,

Share This Twitter Facebook LinkedIn download PDF Gardner Policy Series Maria Kalaitzandonakes and Jonathan Coppess Department of Agricultural and Consumer Economics University of Illinois Brenna Ellison and Trey Malone Department of Agricultural Economics Purdue University March 14, 2025 farmdoc daily ( 15 ): 49 Recommended citation format: Kalaitzandonakes, M., B. Ellison, T. Malone and J. Coppess. " Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players ." farmdoc daily ( 15 ): 49, Department of Agricultural and Consumer Economics, University of Illinois at Urbana-

Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players - farmdoc daily

related reading